Page last updated: 2024-09-03
mosapride and levodopa
mosapride has been researched along with levodopa in 1 studies
Compound Research Comparison
Studies (mosapride) | Trials (mosapride) | Recent Studies (post-2010) (mosapride) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
286 | 90 | 142 | 17,774 | 1,900 | 4,946 |
Protein Interaction Comparison
Protein | Taxonomy | mosapride (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Asai, H; Hirano, M; Kameyama, M; Kubori, T; Minami, T; Nishinaka, K; Oda, M; Udaka, F; Ueno, S | 1 |
Trials
1 trial(s) available for mosapride and levodopa
Article | Year |
---|---|
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzamides; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Levodopa; Morpholines; Parkinson Disease; Positron-Emission Tomography; Receptors, Serotonin, 5-HT4; Serotonin Receptor Agonists; Stomach | 2005 |